PMID: 13998253Jun 1, 1963Paper

Per cent absorbed time plots derived from blood level and/or urinary excretion data

Journal of Pharmaceutical Sciences
J G Wagner, E NELSON

Abstract

No abstract listed.

Citations

May 1, 1990·Journal of Clinical Pharmacology·H DerendorfE van Vliet-Daskalopoulou
Apr 1, 1990·Journal of Clinical Pharmacology·S S ScherzingerI Kanfer
Dec 1, 1995·Journal of Clinical Pharmacology·G J YuenE K Hussey
Mar 1, 1995·Journal of Clinical Pharmacology·S S HwangL Hamel
Jan 1, 1981·European Journal of Clinical Pharmacology·J M LanaoL Corbacho
Dec 16, 1977·European Journal of Clinical Pharmacology·W RiessM Zimmerli
Sep 1, 1971·European Journal of Clinical Pharmacology·R BeckmannE Schmidt-Böthelt
Jan 1, 1983·European Journal of Clinical Pharmacology·M Lagas, J H Jonkman
Jan 1, 1983·European Journal of Clinical Pharmacology·M J NietoJ F Macias
Jan 1, 1983·European Journal of Clinical Pharmacology·V W Steinijans, E Diletti
Jan 1, 1984·European Journal of Clinical Pharmacology·K K Chan, M Gibaldi
Feb 1, 1985·Veterinary Research Communications·U Tanner, A Wuethrich
Jan 1, 1980·European Journal of Drug Metabolism and Pharmacokinetics·M A Kassem, K E Schulte
Jan 1, 1981·European Journal of Drug Metabolism and Pharmacokinetics·M C SauxB Leng
Jan 1, 1984·European Journal of Drug Metabolism and Pharmacokinetics·T NakashimaY Nakanishi
Jul 1, 1992·European Journal of Drug Metabolism and Pharmacokinetics·J A MoraisR Avila
Aug 22, 2012·Pharmaceutical Research·Muhammad Sajid Hamid AkashShuqing Chen
Oct 1, 1986·The Journal of Allergy and Clinical Immunology·J G Wagner
Jan 1, 1981·Pharmacology & Therapeutics·D Cutler
Jun 16, 2005·International Journal of Pharmaceutics·Y W ChoyK H Yuen
Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·Q F XingY W Chien
Sep 22, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·B AbrahamssonA Larsson
Apr 12, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·N HayashiS Higuchi
Feb 19, 2002·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Samar Al-BehaisiImre Klebovich
Aug 9, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Mia SäkkinenMartti Marvola
Mar 11, 1999·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·L BønløkkeH Lennernäs
Jan 5, 2002·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Frieder Langenbucher
Aug 6, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·R L FindlingJ L Blumer
Aug 1, 1974·British Journal of Clinical Pharmacology·D B BarnettC Hetherington
Nov 1, 1993·British Journal of Clinical Pharmacology·W N CharmanG A Fitzgerald
Sep 1, 1990·Journal of Veterinary Pharmacology and Therapeutics·L BaertJ P Remon
Sep 1, 1993·The Journal of Pharmacy and Pharmacology·H A TitulaerJ Zuidema
Jan 1, 1977·Antimicrobial Agents and Chemotherapy·D A SpykerW M O'Brien
Sep 7, 2000·Journal of Clinical Pharmacology·G HochhausH Derendorf
Apr 1, 1977·Journal of Clinical Pharmacology·K J SimonsC W Bierman
Nov 1, 1996·Journal of Clinical Pharmacology·S A ShappellC A DeJohn
May 2, 2012·The AAPS Journal·J-M Cardot, B M Davit
Jan 1, 1993·European Journal of Drug Metabolism and Pharmacokinetics·M Siewert
Jan 1, 1981·Pharmacology & Therapeutics·F Theeuwes
Jan 1, 1981·Pharmacology & Therapeutics·J G Wagner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.